Thermo Fisher Scientific (TMO) Cash from Operations (2009 - 2026)

Thermo Fisher Scientific has reported Cash from Operations for 18 years, with the latest figure at 2125000000.0 in Q2 2026.

• Cash from Operations for Q2 2026 came in at 2125000000.0, up 51.89% year-over-year; the trailing twelve-month figure through Jun 2026 was 9013000000.0 (up 18.94% YoY), and the FY2025 annual result was 7818000000.0, down 9.8% from the prior year.
• Cash from Operations advanced to 2125000000.0 in Q2 2026, from 1192000000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 3723000000.0 in Q4 2023 and troughed at 723000000.0 in Q1 2025.
• A 5-year average of 2075666666.67 and a median of 2042500000.0 in 2024 frame the typical range for Cash from Operations.
• The widest annual swing landed in 2023, when Cash from Operations sank 66.89%; it then soared 71.6% in 2024.
• A 5-year view of Cash from Operations shows it stood at 3487000000.0 in 2022, then increased by 6.77% to 3723000000.0 in 2023, then decreased by 11.63% to 3290000000.0 in 2024, then increased by 5.08% to 3457000000.0 in 2025, then sank by 38.53% to 2125000000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 2125000000.0 in Q2 2026, 1192000000.0 in Q1 2026, and 3457000000.0 in Q4 2025.